MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
Topic
Pharmaceutical Economics and Policy
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

1,682 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
1,682 works in the cohort · of 4,299,418page 22 of 34

Labels cover 5 of 1,682 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 1,682 of 1,682 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

venueno affno abstractunlabeled
10.1016/s1544-8800(08)70406-8
2000· article· en· Time to knit· Economics, Econometrics and Finance
machine prediction:candidate · insufficient_payloadconsensus · insufficient_payload
0
citations
venueno affno abstractunlabeled
10.1016/s1558-0164(07)70380-2
2000· article· en· Time to knit· Economics, Econometrics and Finance
machine prediction:candidate · insufficient_payloadconsensus · insufficient_payload
0
citations
aboutno affno abstractunlabeled
Canada's health system restricts drug access
2000· article· en· PharmacoEconomics & Outcomes News· Economics, Econometrics and Finance
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Data File 1.15 with descriptives
2024· dataset· en· Data Archiving and Networked Services (DANS)· Economics, Econometrics and Finance
machine prediction:candidate · insufficient_payloadconsensus · none
0
citations
aboutno affunlabeled
A Review: Regulatory Affairs in Pharmaceutical Industry
Mr. Karan Durge
2025· article· en· International Journal for Research in Applied Science and Engineering Technology· Economics, Econometrics and Finance
machine prediction:candidate · noneconsensus · none
0
citations
venueno affno abstractunlabeled
10.1016/s1541-9800(06)70999-1
2000· article· en· Time to knit· Economics, Econometrics and Finance
machine prediction:candidate · insufficient_payloadconsensus · insufficient_payload
0
citations
affunlabeled
Political Prioritization of Access to Medicines and Right to Health: Need for an Effective Global Health Governance Through Global Health Diplomacy Comment on "More Pain, More Gain! The Delivery of COVID-19 Vaccines and the Pharmaceutical Industry’s Role in Widening the Access Gap"
Vijay Kumar Chattu, Anjali Pushkaran, Prakash Narayanan
2024· article· en· International Journal of Health Policy and Management· Economics, Econometrics and Finance
machine prediction:candidate · noneconsensus · none
0
citations
venueno affunlabeled
PEI government announces catastrophic drug plan
Karen Birchard
2013· article· en· Canadian Medical Association Journal· Economics, Econometrics and Finance
machine prediction:candidate · noneconsensus · none
0
citations

How this was built: Screen · Findings · About